Regulation of DDAH1 as a potential therapeutic target for treating cardiovascular diseases

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Liu, Xiaoyu ^a   Fassett, John ^b   Wei, Yidong ^a   Chen, Yingjie ^b  

^a TONGJI UNIVERSITY   (China)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 [2 [2 CHLORO 4 [3 (2,6 DICHLOROPHENYL) 5 ISOPROPYL 4 ISOXAZOLYLMETHOXY]PHENYL]VINYL]BENZOIC ACID; BILE ACID; DIMETHYLARGININE DIMETHYLAMINOHYDROLASE 1; ENZYME; FARNESOID X RECEPTOR; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; PEROXYNITRITE; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

ARTICLE; BIOAVAILABILITY; BLOOD FLOW; CARDIOVASCULAR DISEASE; CHINESE MEDICINE; CONGESTIVE HEART FAILURE; DRUG TARGETING; ENZYME DEGRADATION; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

EID: 84880147750     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/619207     Document Type: Article

References (67)

1. Chen C.-A., Druhan L. J., Varadharaj S., Chen Y.-R., Zweier J. L., Phosphorylation of endothelial nitric-oxide synthase regulates superoxide generation from the enzyme. Journal of Biological Chemistry 2008 283 40 27038 27047 2-s2.0-55249112287 10.1074/jbc.M802269200
2. Chen Y., Traverse J. H., Du R., Hou M., Bache R. J., Nitric oxide modulates myocardial oxygen consumption in the failing heart. Circulation 2002 106 2 273 279 2-s2.0-0037047087 10.1161/01.CIR.0000021120.90970.B9 (Pubitemid 34761311)
3. Chen Y., Traverse J. H., Hou M., Li Y., Du R., Bache R. J., Effect of PDE5 inhibition on coronary hemodynamics in pacing-induced heart failure. The American Journal of Physiology 2003 284 5 H1513 H1520 2-s2.0-0037405772 (Pubitemid 36460761)
4. Traverse J. H., Melchert P., Pierpont G. L., Jones B., Crampton M., Bache R. J., Regulation of myocardial blood flow by oxygen consumption is maintained in the failing heart during exercise. Circulation Research 1999 84 4 401 408 2-s2.0-0033525914 (Pubitemid 29120005)
5. Huang P. L., Huang Z., Mashimo H., Bloch K. D., Moskowitz M. A., Bevan J. A., Fishman M. C., Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995 377 6546 239 242 2-s2.0-0029021148
6. Li W., Mital S., Ojaimi C., Csiszar A., Kaley G., Hintze T. H., Premature death and age-related cardiac dysfunction in male eNOS-knockout mice. Journal of Molecular and Cellular Cardiology 2004 37 3 671 680 2-s2.0-4444240923 10.1016/j.yjmcc.2004.05.005 (Pubitemid 39194559)
7. Böger R. H., Sullivan L. M., Schwedhelm E., Wang T. J., Maas R., Benjamin E. J., Schulze F., Xanthakis V., Benndorf R. A., Vasan R. S., Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community. Circulation 2009 119 12 1592 1600 2-s2.0-65249119330 10.1161/CIRCULATIONAHA.108.838268
8. Nicholls S. J., Wang Z., Koeth R., Levison B., Delfraino B., Dzavik V., Griffith O. W., Hathaway D., Panza J. A., Nissen S. E., Hochman J. S., Hazen S. L., Metabolic profiling of arginine and nitric oxide pathways predicts hemodynamic abnormalities and mortality in patients with cardiogenic shock after acute myocardial infarction. Circulation 2007 116 20 2315 2324 2-s2.0-36048946363 10.1161/CIRCULATIONAHA.107.693986 (Pubitemid 350100338)
9. Takimoto E., Champion H. C., Li M., Ren S., Rodriguez E. R., Tavazzi B., Lazzarino G., Paolocci N., Gabrielson K. L., Wang Y., Kass D. A., Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load. Journal of Clinical Investigation 2005 115 5 1221 1231 2-s2.0-20944445197 10.1172/JCI200521968 (Pubitemid 40629040)
10. Barouch L. A., Harrison R. W., Skaf M. W., Rosas G. O., Cappola T. P., Kobeissi Z. A., Hobai I. A., Lemmon C. A., Burnett A. L., O'Rourke B., Rodriguez E. R., Huang P. L., Lima J. A. C., Berkowitz D. E., Hare J. M., Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature 2002 416 6878 337 340 2-s2.0-0037149489 10.1038/416005a (Pubitemid 34260250)
11. Barouch L. A., Cappola T. P., Harrison R. W., Crone J. K., Rodriguez E. R., Burnett A. L., Hare J. M., Combined loss of neuronal and endothelial nitric oxide synthase causes premature mortality and age-related hypertrophic cardiac remodeling in mice. Journal of Molecular and Cellular Cardiology 2003 35 6 637 644 2-s2.0-0038798018 10.1016/S0022-2828(03)00079-8 (Pubitemid 36677447)
12. Jones S. P., Greer J. J. M., van Haperen R., Duncker D. J., de Crom R., Lefer D. J., Endothelial nitric oxide synthase overexpression attenuates congestive heart failure in mice. Proceedings of the National Academy of Sciences of the United States of America 2003 100 8 4891 4896 2-s2.0-0037447249 10.1073/pnas.0837428100 (Pubitemid 36457824)
13. Scherrer-Crosbie M., Ullrich R., Bloch K. D., Nakajima H., Nasseri B., Aretz H. T., Lindsey M. L., Vançon A.-C., Huang P. L., Lee R. T., Zapol W. M., Picard M. H., Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice. Circulation 2001 104 11 1286 1291 2-s2.0-0035845630 (Pubitemid 32848119)
14. Ichinose F., Bloch K. D., Wu J. C., Hataishi R., Aretz H. T., Picard M. H., Scherrer-Crosbie M., Pressure overload-induced LV hypertrophy and dysfunction in mice are exacerbated by congenital NOS3 deficiency. The American Journal of Physiology 2004 286 3 H1070 H1075 2-s2.0-1342325518 (Pubitemid 38248623)
15. Ruetten H., Dimmeler S., Gehring D., Ihling C., Zeiher A. M., Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload. Cardiovascular Research 2005 66 3 444 453 2-s2.0-19444372119 10.1016/j.cardiores.2005.01.021 (Pubitemid 40725756)
16. Buys E. S., Raher M. J., Blake S. L., Neilan T. G., Graveline A. R., Passeri J. J., Llano M., Perez-Sanz T. M., Ichinose F., Janssens S., Zapol W. M., Picard M. H., Bloch K. D., Scherrer-Crosbie M., Cardiomyocyte-restricted restoration of nitric oxide synthase 3 attenuates left ventricular remodeling after chronic pressure overload. The American Journal of Physiology 2007 293 1 H620 H627 2-s2.0-34547096483 10.1152/ajpheart.01236.2006 (Pubitemid 47105123)
17. Janssens S., Pokreisz P., Schoonjans L., Pellens M., Vermeersch P., Tjwa M., Jans P., Scherrer-Crosbie M., Picard M. H., Szelid Z., Gillijns H., Van De Werf F., Collen D., Bloch K. D., Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction. Circulation Research 2004 94 9 1256 1262 2-s2.0-2442678986 10.1161/01.RES.0000126497.38281.23 (Pubitemid 38656413)
18. Mungrue I. N., Gros R., You X., Pirani A., Azad A., Csont T., Schulz R., Butany J., Stewartand D. J., Husain M., Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death. Journal of Clinical Investigation 2002 109 6 735 743 2-s2.0-0036196099 10.1172/JCI200213265 (Pubitemid 34263150)
19. Haywood G. A., Tsao P. S., von der Leyen H. E., Mann M. J., Keeling P. J., Trindade P. T., Lewis N. P., Byrne C. D., Rickenbacher P. R., Bishopric N. H., Cooke J. P., McKenna W. J., Fowler M. B., Expression of inducible nitric oxide synthase in human heart failure. Circulation 1996 93 6 1087 1094 2-s2.0-9044252721 (Pubitemid 26087012)
20. Habib F. M., Springall D. R., Davies G. J., Oakley C. M., Yacoub M. H., Polak J. M., Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. The Lancet 1996 347 9009 151 155 2-s2.0-0029967492 (Pubitemid 26127024)
21. Zhang P., Xu X., Hu X., Van Deel E. D., Zhu G., Chen Y., Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure. Circulation Research 2007 100 7 1089 1098 2-s2.0-34247160943 10.1161/01.RES.0000264081.78659.45 (Pubitemid 46598934)
22. Cardounel A. J., Cui H., Samouilov A., Johnson W., Kearns P., Tsai A.-L., Berka V., Zweier J. L., Evidence for the pathophysiological role of endogenous methylarginines in regulation of endothelial no production and vascular function. Journal of Biological Chemistry 2007 282 2 879 887 2-s2.0-33847757915 10.1074/jbc.M603606200 (Pubitemid 47076535)
23. Feng Q., Xiangru L., Fortin A. J., Pettersson A., Hedner T., Kline R. L., Arnold J. M. O., Elevation of an endogenous inhibitor of nitric oxide synthesis in experimental congestive heart failure. Cardiovascular Research 1998 37 3 667 675 2-s2.0-0032029297 10.1016/S0008-6363(97)00242-3 (Pubitemid 28231161)
24. Kielstein J. T., Bode-Böger S. M., Klein G., Graf S., Haller H., Fliser D., Endogenous nitric oxide synthase inhibitors and renal perfusion in patients with heart failure. European Journal of Clinical Investigation 2003 33 5 370 375 2-s2.0-0038583722 10.1046/j.1365-2362.2003.01149.x (Pubitemid 36583703)
25. Surdacki A., Nowicki M., Sandmann J., Tsikas D., Boeger R. H., Bode-Boeger S. M., Kruszelnicka-Kwiatkowska O., Kokot F., Dubiel J. S., Froelich J. C., Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension. Journal of Cardiovascular Pharmacology 1999 33 4 652 658 2-s2.0-0032912757 10.1097/00005344-199904000-00020 (Pubitemid 29164831)
26. Sydow K., Mondon C. E., Cooke J. P., Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA. Vascular Medicine 2005 10 1 S35 S43 2-s2.0-31344449864 10.1191/1358863x05vm604oa (Pubitemid 43137266)
27. Böger R. H., Bode-Böger S. M., Tsao P. S., Lin P. S., Chan J. R., Cooke J. P., An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes. Journal of the American College of Cardiology 2000 36 7 2287 2295 2-s2.0-0033667562 10.1016/S0735-1097(00)01013-5
28. Xiao H.-B., Yang Z.-C., Jia S.-J., Li N.-S., Jiang D.-J., Zhang X.-H., Guo R., Zhou Z., Deng H.-W., Li Y.-J., Effect of asymmetric dimethylarginine on atherogenesis and erythrocyte deformability in apolipoprotein E deficient mice. Life Sciences 2007 81 1 1 7 2-s2.0-34250025922 10.1016/j.lfs.2007.04.019 (Pubitemid 46891499)
29. Chen Y., Li Y., Zhang P., Traverse J. H., Hou M., Xu X., Kimoto M., Bache R. J., Dimethylarginine dimethylaminohydrolase and endothelial dysfunction in failing hearts. The American Journal of Physiology 2005 289 5 H2212 H2219 2-s2.0-27144436415 10.1152/ajpheart.00224.2005 (Pubitemid 41507375)
30. Cosentino F., Patton S., d'Uscio L. V., Werner E. R., Werner-Felmayer G., Moreau P., Malinski T., Luscher T. F., Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats. Journal of Clinical Investigation 1998 101 7 1530 1537 (Pubitemid 28166851)
31. Landmesser U., Dikalov S., Price S. R., McCann L., Fukai T., Holland S. M., Mitch W. E., Harrison D. G., Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. Journal of Clinical Investigation 2003 111 8 1201 1209 2-s2.0-0037399439 10.1172/JCI200314172 (Pubitemid 36519937)
32. Xia Y., Dawson V. L., Dawson T. M., Snyder S. H., Zweier J. L., Nitric oxide synthase generates Superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proceedings of the National Academy of Sciences of the United States of America 1996 93 13 6770 6774 2-s2.0-0029900905
33. Zou M.-H., Shi C., Cohen R. A., Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. Journal of Clinical Investigation 2002 109 6 817 826 2-s2.0-0036199685 10.1172/JCI200214442 (Pubitemid 34263158)
34. Baek K. J., Thiel B. A., Lucas S., Stuehr D. J., Macrophage nitric oxide synthase subunits. Purification, characterization, and role of prosthetic groups and substrate in regulating their association into a dimeric enzyme. Journal of Biological Chemistry 1993 268 28 21120 21129 2-s2.0-0027441142 (Pubitemid 23292298)
35. Crane B. R., Arvai A. S., Ghosh D. K., Wu C., Getzoff E. D., Stuehr D. J., Tainer J. A., Structure of nitric oxide synthase oxygenase dimer with pterin and substrate. Science 1998 279 5359 2121 2126 2-s2.0-0032571411 10.1126/science.279.5359.2121 (Pubitemid 28196359)
36. Xia Y., Zweier J. L., Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proceedings of the National Academy of Sciences of the United States of America 1997 94 13 6954 6958 2-s2.0-0031002421 10.1073/pnas.94.13.6954 (Pubitemid 27281972)
37. Olken N. M., Osawa Y., Marletta M. A., Characterization of the inactivation of nitric oxide synthase by N(G)-methyl-L-arginine: evidence for heme loss. Biochemistry 1994 33 49 14784 14791 2-s2.0-0028567798 10.1021/bi00253a017
38. Cardounel A. J., Xia Y., Zweier J. L., Endogenous methylarginines modulate superoxide as well as nitric oxide generation from neuronal nitric-oxide synthase: differences in the effects of monomethyl- and dimethylarginines in the presence and absence of tetrahydrobiopterin. Journal of Biological Chemistry 2005 280 9 7540 7549 2-s2.0-14844327786 10.1074/jbc.M410241200 (Pubitemid 40349646)
39. Scalera F., Borlak J., Beckmann B., Martens-Lobenhoffer J., Thum T., Täger M., Bode-Böger S. M., Endogenous nitric oxide synthesis inhibitor asymmetric dimethyl L-arginine accelerates endothelial cell senescence. Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 10 1816 1822 2-s2.0-5344246626 10.1161/01.ATV.0000141843.77133.fc (Pubitemid 39350297)
40. Toth J., Racz A., Kaminski P. M., Wolin M. S., Bagi Z., Koller A., Asymmetrical dimethylarginine inhibits shear stress-induced nitric oxide release and dilation and elicits superoxide-mediated increase in arteriolar tone. Hypertension 2007 49 3 563 568 2-s2.0-33847068349 10.1161/01.HYP.0000256764. 86208.3d
41. Wells S. M., Holian A., Asymmetric dimethylarginine induces oxidative and nitrosative stress in murine lung epithelial cells. The American Journal of Respiratory Cell and Molecular Biology 2007 36 5 520 528 2-s2.0-34247625981 10.1165/rcmb.2006-0302SM (Pubitemid 46676710)
42. G-dimethyl-L-arginine to L-citrulline in rats. Biochemical and Biophysical Research Communications 1987 148 2 671 677 2-s2.0-0023667668
43. Leiper J. M., Santa Maria J., Chubb A., MacAllister R. J., Charles I. G., Whitley G. S. J., Vallance P., Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases. Biochemical Journal 1999 343 1 209 214 2-s2.0-0033214074 10.1042/0264-6021:3430209 (Pubitemid 29473897)
44. Tran C. T. L., Fox M. F., Vallance P., Leiper J. M., Chromosomal localization, gene structure, and expression pattern of DDAH1: comparison with DDAH2 and implications for evolutionary origins. Genomics 2000 68 1 101 105 2-s2.0-0034662784 10.1006/geno.2000.6262
45. Arrigoni F. I., Vallance P., Haworth S. G., Leiper J. M., Metabolism of asymmetric dimethylarginines is regulated in the lung developmentally and with pulmonary hypertension induced by hypobaric hypoxia. Circulation 2003 107 8 1195 1201 2-s2.0-0037418212 10.1161/01.CIR.0000051466.00227.13 (Pubitemid 36297214)
46. Hu X., Atzler D., Xu X., Zhang P., Guo H., Lu Z., Fassett J., Schwedhelm E., Böger R. H., Bache R. J., Chen Y., Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine. Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 7 1540 1546 2-s2.0-79959707563 10.1161/ATVBAHA.110. 222638
47. Dayoub H., Achan V., Adimoolam S., Jacobi J., Stuehlinger M. C., Wang B.-Y., Tsao P. S., Kimoto M., Vallance P., Patterson A. J., Cooke J. P., Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence. Circulation 2003 108 24 3042 3047 2-s2.0-0346365087 10.1161/01.CIR.0000101924.04515.2E (Pubitemid 37553576)
48. Hu X., Xu X., Zhu G., Atzler D., Kimoto M., Chen J., Schwedhelm E., Lüneburg N., Böger R. H., Zhang P., Chen Y., Vascular endothelial-specific dimethylarginine dimethylaminohydrolase-1-deficient mice reveal that vascular endothelium plays an important role in removing asymmetric dimethylarginine. Circulation 2009 120 22 2222 2229 2-s2.0-73449121413 10.1161/CIRCULATIONAHA.108.819912
49. Leiper J., Nandi M., Torondel B., Murray-Rust J., Malaki M., O'Hara B., Rossiter S., Anthony S., Madhani M., Selwood D., Smith C., Wojciak-Stothard B., Rudiger A., Stidwill R., McDonald N. Q., Vallance P., Disruption of methylarginine metabolism impairs vascular homeostasis. Nature Medicine 2007 13 2 198 203 2-s2.0-33847005404 10.1038/nm1543
50. Zhang P., Hu X., Xu X., Chen Y., Bache R. J., Dimethylarginine dimethylaminohydrolase 1 modulates endothelial cell growth through nitric oxide and Akt. Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 4 890 897 2-s2.0-79953748148 10.1161/ATVBAHA.110.215640
51. Ikegami T., Matsuzaki Y., Ursodeoxycholic acid: mechanism of action and novel clinical applications. Hepatology Research 2008 38 2 123 131 2-s2.0-38049109883 10.1111/j.1872-034X.2007.00297.x
52. Hylemon P. B., Zhou H., Pandak W. M., Ren S., Gil G., Dent P., Bile acids as regulatory molecules. Journal of Lipid Research 2009 50 8 1509 1520 2-s2.0-69449095892 10.1194/jlr.R900007-JLR200
53. Trauner M., Claudel T., Fickert P., Moustafa T., Wagner M., Bile acids as regulators of hepatic lipid and glucose metabolism. Digestive Diseases 2010 28 1 220 224 2-s2.0-77952561299 10.1159/000282091
54. Parks D. J., Blanchard S. G., Bledsoe R. K., Chandra G., Consler T. G., Kliewer S. A., Stimmel J. B., Willson T. M., Zavacki A. M., Moore D. D., Lehmann J. M., Bile acids: natural ligands for an orphan nuclear receptor. Science 1999 284 5418 1365 1368 2-s2.0-0033591387 10.1126/science.284.5418.1365 (Pubitemid 29289664)
55. Sinisalo J., Vanhanen H., Pajunen P., Vapaatalo H., Nieminen M. S., Ursodeoxycholic acid and endothelial-dependent, nitric oxide-independent vasodilatation of forearm resistance arteries in patients with coronary heart disease. British Journal of Clinical Pharmacology 1999 47 6 661 665 2-s2.0-0032999801 10.1046/j.1365-2125.1999.00940.x (Pubitemid 29257664)
56. Maloney P. R., Parks D. J., Haffner C. D., Fivush A. M., Chandra G., Plunket K. D., Creech K. L., Moore L. B., Wilson J. G., Lewis M. C., Jones S. A., Willson T. M., Identification of a chemical tool for the orphan nuclear receptor FXR. Journal of Medicinal Chemistry 2000 43 16 2971 2974 2-s2.0-0034632762 10.1021/jm0002127 (Pubitemid 30626755)
57. Ma K., Saha P. K., Chan L., Moore D. D., Farnesoid X receptor is essential for normal glucose homeostasis. Journal of Clinical Investigation 2006 116 4 1102 1109 2-s2.0-33645509321 10.1172/JCI25604
58. Sinal C. J., Tohkin M., Miyata M., Ward J. M., Lambert G., Gonzalez F. J., Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 2000 102 6 731 744 2-s2.0-0034664729
59. Talwalkar J. A., Lindor K. D., Primary biliary cirrhosis. The Lancet 2003 362 9377 53 61 2-s2.0-0037487251 10.1016/S0140-6736(03)13808-1 (Pubitemid 36835823)
60. Schild L., Dombrowski F., Lendeckel U., Schulz C., Gardemann A., Keilhoff G., Impairment of endothelial nitric oxide synthase causes abnormal fat and glycogen deposition in liver. Biochimica et Biophysica Acta 2008 1782 3 180 187 2-s2.0-39149116709 10.1016/j.bbadis.2007.12.007
61. Schild L., Jaroscakova I., Lendeckel U., Wolf G., Keilhoff G., Neuronal nitric oxide synthase controls enzyme activity pattern of mitochondria and lipid metabolism. FASEB Journal 2006 20 1 145 147 2-s2.0-30744442160 10.1096/fj.05-3898fje (Pubitemid 43100495)
62. Özcan U., Yilmaz E., Özcan L., Furuhashi M., Vaillancourt E., Smith R. O., Görgün C. Z., Hotamisligil G. S., Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 2006 313 5790 1137 1140 2-s2.0-33748069813 10.1126/science.1128294 (Pubitemid 44300242)
63. von Haehling S., Schefold J. C., Jankowska E. A., Springer J., Vazir A., Kalra P. R., Sandek A., Fauler G., Stojakovic T., Trauner M., Ponikowski P., Volk H.-D., Doehner W., Coats A. J. S., Poole-Wilson P. A., Anker S. D., Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial. Journal of the American College of Cardiology 2012 59 6 585 592 2-s2.0-84856438707 10.1016/j.jacc.2011.10.880
64. Hu T., Chouinard M., Cox A. L., Sipes P., Marcelo M., Ficorilli J., Li S., Gao H., Ryan T. P., Michael M. D., Michael L. F., Farnesoid X receptor agonist reduces serum asymmetric dimethylarginine levels through hepatic dimethylarginine dimethylaminohydrolase-1 gene regulation. Journal of Biological Chemistry 2006 281 52 39831 39838 2-s2.0-33846027539 10.1074/jbc.M606779200 (Pubitemid 46041786)
65. Li J., Wilson A., Gao X., Kuruba R., Liu Y., Poloyac S., Pitt B., Xie W., Li S., Coordinated regulation of dimethylarginine dimethylaminohydrolase-1 and cationic amino acid transporter-1 by farnesoid X receptor in mouse liver and kidney and its implication in the control of blood levels of asymmetric dimethylarginine. Journal of Pharmacology and Experimental Therapeutics 2009 331 1 234 243 2-s2.0-70349306439 10.1124/jpet.109.153510
66. Mencarelli A., Cipriani S., Renga B., D'Amore C., Palladino G., Distrutti E., Baldelli F., Fiorucci S., FXR activation improves myocardial fatty acid metabolism in a rodent model of obesity-driven cardiotoxicity. Nutrition, Metabolism and Cardiovascular Diseases 2013 23 94 101 2-s2.0-80052672904
67. Zhang L., Li T., Yu D., Forman B. M., Huang W., FXR protects lung from lipopolysaccharide-induced acute injury. Molecular Endocrinology 2012 26 1 27 36 2-s2.0-84855231518 10.1210/me.2011-0042